| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.80e-05 | 37 | 207 | 5 | GO:0140658 | |
| GeneOntologyMolecularFunction | xylose binding | 1.07e-04 | 2 | 207 | 2 | GO:0033222 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G MYH8 MYH11 ERCC6 ZGRF1 ARID1A DHX8 ATP2C2 HFM1 DDX60L SMARCA5 KIF26B CECR2 CCT4 ATP2A2 DHX34 HELLS | 2.37e-04 | 614 | 207 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | helicase activity | 2.48e-04 | 158 | 207 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.63e-04 | 127 | 207 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | D-glucose binding | 3.67e-04 | 14 | 207 | 3 | GO:0005536 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.81e-05 | 114 | 207 | 8 | GO:0016528 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.72e-05 | 88 | 207 | 7 | GO:0016529 | |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH8 SYNPO2 MYH11 CMYA5 RYR3 ANKRD2 SVIL SYNE2 SORBS2 ANK3 SYNE1 | 1.57e-04 | 290 | 207 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | actin cytoskeleton | MYO1G ARHGAP32 MYH8 SYNPO2 MYH11 AIF1L SVIL FGR AMPH SHROOM3 SORBS2 ITSN1 CLIC4 SRCIN1 MICAL2 AKAP13 | 2.11e-04 | 576 | 207 | 16 | GO:0015629 |
| GeneOntologyCellularComponent | transcription elongation factor complex | 2.30e-04 | 56 | 207 | 5 | GO:0008023 | |
| GeneOntologyCellularComponent | myofibril | 4.11e-04 | 273 | 207 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | aggresome | 6.46e-04 | 40 | 207 | 4 | GO:0016235 | |
| GeneOntologyCellularComponent | presynaptic endocytic zone | 7.00e-04 | 18 | 207 | 3 | GO:0098833 | |
| GeneOntologyCellularComponent | sarcomere | 8.74e-04 | 249 | 207 | 9 | GO:0030017 | |
| Domain | Glc_transpt_3 | 1.19e-04 | 2 | 204 | 2 | IPR002945 | |
| Domain | Helicase_C | 1.73e-04 | 107 | 204 | 7 | PF00271 | |
| Domain | HELICc | 1.73e-04 | 107 | 204 | 7 | SM00490 | |
| Domain | Helicase_C | 1.84e-04 | 108 | 204 | 7 | IPR001650 | |
| Domain | HELICASE_CTER | 1.95e-04 | 109 | 204 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.95e-04 | 109 | 204 | 7 | PS51192 | |
| Domain | DEXDc | 1.95e-04 | 109 | 204 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.06e-04 | 110 | 204 | 7 | IPR014001 | |
| Domain | HMGI/Y_DNA-bd_CS | 3.45e-04 | 31 | 204 | 4 | IPR000637 | |
| Domain | C2_dom | 4.50e-04 | 164 | 204 | 8 | IPR000008 | |
| Domain | AT_hook | 6.47e-04 | 16 | 204 | 3 | PF02178 | |
| Domain | CTF_NFI | 7.02e-04 | 4 | 204 | 2 | PF00859 | |
| Domain | CTF_NFI_1 | 7.02e-04 | 4 | 204 | 2 | PS00349 | |
| Domain | KASH | 7.02e-04 | 4 | 204 | 2 | IPR012315 | |
| Domain | CTF_NFI_2 | 7.02e-04 | 4 | 204 | 2 | PS51080 | |
| Domain | KASH | 7.02e-04 | 4 | 204 | 2 | PS51049 | |
| Domain | CTF/NFI_DNA-bd-dom | 7.02e-04 | 4 | 204 | 2 | IPR020604 | |
| Domain | KASH | 7.02e-04 | 4 | 204 | 2 | SM01249 | |
| Domain | NfI_DNAbd_pre-N | 7.02e-04 | 4 | 204 | 2 | PF10524 | |
| Domain | KASH | 7.02e-04 | 4 | 204 | 2 | PF10541 | |
| Domain | CTF/NFI | 7.02e-04 | 4 | 204 | 2 | IPR000647 | |
| Domain | CTF/NFI_DNA-bd_N | 7.02e-04 | 4 | 204 | 2 | IPR019548 | |
| Domain | CTF/NFI_DNA-bd_CS | 7.02e-04 | 4 | 204 | 2 | IPR019739 | |
| Domain | CH | 7.19e-04 | 65 | 204 | 5 | SM00033 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 5.32e-06 | 45 | 141 | 6 | M39615 | |
| Pubmed | NR2C2 ARHGAP32 TRAF3 GPATCH4 ARID1A SPATA2 KMT2C JUND FAT1 BBX ZNF608 NFIB NFIC SVIL SYNE2 HERC1 TAF9 QKI CBX2 TSHZ3 SMARCA5 RBBP6 ZNF507 CCT4 HNRNPUL1 ZHX2 SDAD1 CDC37 NOP14 RESF1 GTF3C1 FTL SPEN ATP2A2 SNRPD2 HELLS | 4.75e-13 | 1429 | 212 | 36 | 35140242 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ERCC6 MAP4 CKAP5 GPATCH4 URB2 DNTTIP2 DHX8 DGCR8 SPATS2 PLRG1 SMARCA5 MAP7D3 RBBP6 HNRNPUL1 SDAD1 NGDN MB21D2 NOP14 GTF3C1 UPF2 PRPF3 PHF3 CDK13 EIF2B1 SNRPD2 | 9.25e-12 | 759 | 212 | 25 | 35915203 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCP110 ARHGAP32 MAP4 TBC1D5 CKAP5 ARHGEF17 FSIP2 SYDE2 SVIL SYNE2 OSBPL6 NADK SHROOM3 RAP1GAP SORBS2 MAP7D3 KIF26B HNRNPUL1 C2CD3 RESF1 PHF3 AASS AKAP13 CRYBG3 CTNND1 | 1.33e-10 | 861 | 212 | 25 | 36931259 |
| Pubmed | NR2C2 ERCC6 GPATCH4 DNTTIP2 DHX8 JUND NFIB NFIC SPATS2 QKI PLRG1 SMARCA5 RBBP6 CCT4 CPS1 SDAD1 NGDN NOP14 GTF3C1 PRPF3 PHF3 CTNND1 ATP2A2 SNRPD2 | 5.19e-10 | 847 | 212 | 24 | 35850772 | |
| Pubmed | ARHGAP32 MYH11 MAP4 VPS45 CKAP5 ARID1A ARHGEF17 DNAJC6 SPON1 SVIL OSBPL6 MICAL3 AMPH RAP1GAP SORBS2 ANK3 SYNE1 PCLO ITSN1 SLC2A14 CCT4 SRCIN1 IDH3A SLC2A3 KHSRP UPF2 MICAL2 ELAVL3 CTNND1 ATP2A2 SNRPD2 | 9.61e-10 | 1431 | 212 | 31 | 37142655 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ERCC6 GPRIN1 RYR3 RTF1 KMT2C USP32 MICAL3 HERC1 PLRG1 SMARCA5 ANK3 SRCIN1 TMEM87A SDAD1 SNX14 GTF3C1 CTNND1 HELLS | 1.98e-09 | 497 | 212 | 18 | 36774506 |
| Pubmed | ARHGAP32 GOLGA6L2 URB2 ARID1A FER1L6 EHBP1L1 NFIB FDFT1 SYNE2 HFM1 LRRC41 MAP7D3 REV3L NGDN RAB3GAP1 ALX1 AASS GYS1 SPEN HELLS | 2.88e-09 | 638 | 212 | 20 | 31182584 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NR2C2 CKAP5 GPATCH4 ARID1A DNTTIP2 DHX8 KMT2C JUND BBX NFIB NFIC TAF9 ANAPC7 PLRG1 SMARCA5 MAP7D3 RBBP6 HNRNPUL1 NGDN SETD2 GTF3C1 PRPF3 PHF3 CDK13 SPEN ATP2A2 SNRPD2 HELLS | 6.95e-09 | 1294 | 212 | 28 | 30804502 |
| Pubmed | ERCC6 MAP4 VPS45 CKAP5 GPATCH4 AIF1L URB2 DHX8 KMT2C BBX NFIB DGCR8 SPATS2 TAF9 ANAPC7 SHROOM3 RBBP6 NOA1 SYNE1 CCT4 ICE1 ZHX2 SDAD1 NGDN SETD2 NOP14 PHF3 CDK13 SPEN ATP2A2 | 1.09e-08 | 1497 | 212 | 30 | 31527615 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ARID1A DHX8 EHBP1L1 BBX TAF9 PLRG1 NPAS2 SMARCA5 SORBS2 RBBP6 SYNE1 CECR2 HNRNPUL1 SDAD1 KHSRP SETD2 NOP14 GTF3C1 UPF2 PRPF3 GYS1 ELAVL3 SPEN ATP2A2 SNRPD2 | 1.34e-08 | 1082 | 212 | 25 | 38697112 |
| Pubmed | NR2C2 MAP4 CKAP5 ARID1A KMT2C JUND XPO5 NFIC TAF9 QKI ANAPC7 PLRG1 ZNF507 CCT4 HNRNPUL1 KHSRP NOP14 RESF1 GTF3C1 PRPF3 CDK13 SPEN ATP2A2 SNRPD2 HELLS | 1.95e-08 | 1103 | 212 | 25 | 34189442 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAP4 CKAP5 GPATCH4 DHX8 SMG9 SPATS2 ANAPC7 PLRG1 MAP7D3 C16orf96 KHSRP NGDN UPF2 PHF3 CD44 AKAP13 CTNND1 SPEN ATP2A2 HELLS | 2.37e-08 | 724 | 212 | 20 | 36232890 |
| Pubmed | ERCC6 GPATCH4 SCEL ARID1A ITIH4 DNTTIP2 FAT1 SENP1 ZNF608 ANKRD2 RTL9 TAF9 ANAPC7 QSOX2 LRRC41 SMARCA5 RBBP6 CECR2 C16orf96 REV3L SETD2 RESF1 PRPF3 CRYBG3 DHX34 | 2.45e-08 | 1116 | 212 | 25 | 31753913 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NR2C2 MAP4 GPATCH4 ARID1A DNTTIP2 BBX DGCR8 TAF9 PLRG1 CBX2 SMARCA5 MAP7D3 RBBP6 ICE1 HNRNPUL1 KHSRP SETD2 PRPF3 PHF3 SPEN ATP2A2 SNRPD2 HELLS | 2.47e-08 | 954 | 212 | 23 | 36373674 |
| Pubmed | ARHGAP32 EMC3 TBC1D5 ARID1A GPRIN1 PHKA1 FDFT1 SVIL SYNE2 MICAL3 HERC1 CBX2 ANK3 CCT4 SDAD1 C2CD3 NOP14 PRPF3 CD44 CRYBG3 CTNND1 ATP2A2 SNRPD2 HELLS | 3.22e-08 | 1049 | 212 | 24 | 27880917 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | NR2C2 ERCC6 GPATCH4 DNTTIP2 DHX8 FSIP2 BBX NFIC ANAPC7 LRRC41 CBX2 TSHZ3 SMARCA5 NOP14 GTF3C1 PHF3 SPEN HELLS | 4.37e-08 | 608 | 212 | 18 | 36089195 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MAP4 CKAP5 GPATCH4 URB2 CMYA5 DNTTIP2 DHX8 XPO5 ANAPC7 PLRG1 NPAS2 SMARCA5 SYNE1 PCLO CCT4 IDH3A HNRNPUL1 SDAD1 KHSRP CDC37 GTF3C1 EIF2B1 CD47 CTNND1 SPEN ATP2A2 SNRPD2 HELLS | 5.33e-08 | 1425 | 212 | 28 | 30948266 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MAP4 CKAP5 FCHO1 FAT1 NADK ANK3 RBBP6 ICE1 NGDN PHF3 CDK13 ELAVL3 AKAP13 SPEN | 5.64e-08 | 361 | 212 | 14 | 26167880 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ERCC6 MAP4 CKAP5 GPATCH4 URB2 ARID1A DNTTIP2 DDX60L PLRG1 SMARCA5 CLIC4 CCT4 HNRNPUL1 KHSRP NGDN CDC37 RAB3GAP1 NOP14 GTF3C1 UPF2 PRPF3 MICAL2 AKAP13 CTNND1 ATP2A2 DHX34 SNRPD2 | 6.92e-08 | 1353 | 212 | 27 | 29467282 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MAP4 CKAP5 GPRIN1 TBC1D9 JUND NFIC SVIL MICAL3 SMARCA5 SORBS2 RBBP6 ITSN1 ZNF507 HNRNPUL1 SETD2 GTF3C1 PHF3 CDK13 SPEN ATP2A2 | 7.01e-08 | 774 | 212 | 20 | 15302935 |
| Pubmed | TDRD15 VPS45 GPATCH4 SPATA2 GPRIN1 FAT1 BBX SYDE2 DGCR8 SHROOM3 MAP7D3 ANK3 CCT4 HNRNPUL1 TENM3 CD44 PRKCH CTNND1 SPEN HELLS | 7.47e-08 | 777 | 212 | 20 | 35844135 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | TDRD15 CCDC168 RYR3 FSIP2 BBX QSOX2 SHROOM3 SYNE1 MICAL2 AKAP13 | 9.31e-08 | 168 | 212 | 10 | 30631154 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP4 VPS45 TBC1D5 ARID1A PCNX2 KMT2C SENP1 ZNF608 NFIB NFIC KCNJ3 MICAL3 SPATS2 POLK LRRC41 NPAS2 SHROOM3 ANK3 FRMPD2 SRCIN1 ZHX2 GTF3C1 PRPF3 MICAL2 CDK13 SETBP1 AKAP13 CTNND1 | 1.32e-07 | 1489 | 212 | 28 | 28611215 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | NR2C2 MAP4 DNTTIP2 DHX8 RTF1 BBX SMARCA5 RBBP6 KHSRP PRPF3 PHF3 SPEN | 1.98e-07 | 283 | 212 | 12 | 30585729 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | URB2 DNTTIP2 RTF1 XPO5 NFIC DGCR8 TAF9 PLRG1 CBX2 SMARCA5 CLIC4 CCT4 HNRNPUL1 SDAD1 KHSRP NGDN NOP14 GTF3C1 PHF3 CTNND1 ATP2A2 SNRPD2 | 2.02e-07 | 989 | 212 | 22 | 36424410 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ERCC6 MAP4 CKAP5 DNTTIP2 DHX8 SVIL SPATS2 PLRG1 SMARCA5 MAP7D3 RBBP6 CCT4 HNRNPUL1 SDAD1 NGDN CDC37 NOP14 GTF3C1 UPF2 PRPF3 PHF3 LRRC8A CTNND1 SPEN SNRPD2 | 2.35e-07 | 1257 | 212 | 25 | 36526897 |
| Pubmed | CKAP5 URB2 SPATA2 ARHGEF17 DNAJC6 SEMA6D XPO5 MICAL3 SORBS2 SYNE1 ZHX2 TENM3 PHF3 SPEN | 2.44e-07 | 407 | 212 | 14 | 12693553 | |
| Pubmed | FAM184B MYH8 MYH11 MYNN ARID1A DNTTIP2 FER1L6 IVD BBX ZNF608 SLC22A14 SYNE2 ANAPC7 SMARCA5 SYNE1 PCLO ITSN1 CCT4 KHSRP NGDN C2CD3 NOP14 GTF3C1 CDK13 UGGT2 SPEN ATP2A2 | 2.45e-07 | 1442 | 212 | 27 | 35575683 | |
| Pubmed | GPATCH4 URB2 DNTTIP2 DHX8 DGCR8 SPATS2 SMARCA5 CCT4 SDAD1 KHSRP NGDN NOP14 GTF3C1 CDK13 ATP2A2 | 3.31e-07 | 483 | 212 | 15 | 36912080 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EMC3 MAP4 CKAP5 URB2 DNTTIP2 DHX8 SVIL SYNE2 ANAPC7 SMARCA5 SYNE1 CCT4 IDH3A HNRNPUL1 KHSRP GTF3C1 PRPF3 CTNND1 SPEN ATP2A2 SNRPD2 HELLS | 3.64e-07 | 1024 | 212 | 22 | 24711643 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH11 MAP4 GPATCH4 DNTTIP2 DHX8 SENP1 SVIL SMARCA5 MAP7D3 RBBP6 SYNE1 CCT4 HNRNPUL1 CPS1 NGDN PRPF3 CDK13 EIF2B1 CD44 ATP2A2 SNRPD2 | 4.23e-07 | 949 | 212 | 21 | 36574265 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ARHGAP32 MAP4 CKAP5 SCEL GPRIN1 EHBP1L1 SVIL SHROOM3 ANK3 SLC2A14 SRCIN1 TMEM87A NGDN MB21D2 TENM3 CTNND1 | 4.55e-07 | 565 | 212 | 16 | 25468996 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | EMC3 TMEM126B GPATCH4 ARMCX4 IVD SENP1 SYNE2 SPATS2 HERC1 QKI ANAPC7 MAP7D3 NOA1 SYNE1 PCLO CCT4 IDH3A HNRNPUL1 CDC37 RAB3GAP1 NOP14 UPF2 AASS CDK13 PRKCH CRYBG3 ATP2A2 | 5.02e-07 | 1496 | 212 | 27 | 32877691 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | MAP4 RPS6KA3 CKAP5 GPATCH4 ARID1A QKI ANAPC7 PLRG1 SMARCA5 CCT4 NOP14 GTF3C1 PHF3 | 5.21e-07 | 370 | 212 | 13 | 22922362 |
| Pubmed | ARHGAP32 TRAF3 TBC1D5 CKAP5 ARMCX4 DNAJC6 ITIH4 SENP1 SVIL SYNE2 PPP1R3F SPATS2 SHROOM3 SORBS2 ANK3 SYNE1 ITSN1 CCT4 KHSRP ELAVL3 CTNND1 | 5.36e-07 | 963 | 212 | 21 | 28671696 | |
| Pubmed | NR2C2 ARID1A NFIC DGCR8 CBX2 MMS22L ICE1 HNRNPUL1 ZHX2 KHSRP SETD2 GTF3C1 PHF3 ATP2A2 | 8.74e-07 | 453 | 212 | 14 | 29656893 | |
| Pubmed | 1.05e-06 | 169 | 212 | 9 | 31462741 | ||
| Pubmed | CKAP5 URB2 DNTTIP2 DHX8 SVIL DDX60L SPATS2 PLRG1 SMARCA5 SYNE1 NGDN CTNND1 | 1.07e-06 | 332 | 212 | 12 | 25693804 | |
| Pubmed | MAP4 RTF1 XPO5 NFIB NFIC TAF9 ANAPC7 PLRG1 SMARCA5 RBBP6 CCT4 KHSRP CDC37 SETD2 GTF3C1 PRPF3 PHF3 CDK13 EIF2B1 CTNND1 HELLS | 1.22e-06 | 1014 | 212 | 21 | 32416067 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MAP4 TBC1D5 CKAP5 GPATCH4 GPRIN1 DNTTIP2 ALDH1A2 PLRG1 SMARCA5 MAP7D3 RBBP6 CCT4 ICE1 HNRNPUL1 KHSRP CDC37 SETD2 PRPF3 CTNND1 HELLS | 1.34e-06 | 934 | 212 | 20 | 33916271 |
| Pubmed | 1.37e-06 | 225 | 212 | 10 | 12168954 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ARHGAP32 VPS45 TBC1D5 CKAP5 SPATA2 SENP1 ALDH1A2 CCDC66 SVIL NADK MICAL3 SHROOM3 MAP7D3 ITSN1 ZNF507 CCT4 C2CD3 AASS BORA | 1.40e-06 | 853 | 212 | 19 | 28718761 |
| Pubmed | FAM184B NR2C2 EMC3 TMEM126B GPRIN1 DNAJC6 DNTTIP2 SENP1 FDFT1 SYNE2 PLRG1 LRRC41 SHROOM3 ANK3 SYNE1 ITSN1 HNRNPUL1 CDC37 RAB3GAP1 NOP14 UGGT2 AKAP13 CRYBG3 CTNND1 ATP2A2 HELLS | 1.50e-06 | 1487 | 212 | 26 | 33957083 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NR2C2 CKAP5 JUND BBX NFIC TAF9 ANAPC7 LRRC41 SMARCA5 ZCWPW1 MAP7D3 REV3L CPS1 KHSRP NOP14 GTF3C1 CTNND1 SPEN HELLS | 1.50e-06 | 857 | 212 | 19 | 25609649 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | NR2C2 GPATCH4 DNTTIP2 BBX NFIC SPATS2 SDAD1 KHSRP GTF3C1 PRPF3 CDK13 SPEN ATP2A2 | 1.63e-06 | 410 | 212 | 13 | 26949251 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ARHGAP32 SYNPO2 SPATA31E1 TBC1D5 KCNJ3 TSHZ3 SHROOM3 ANK3 RBBP6 ITSN1 SETBP1 AKAP13 SPEN | 2.75e-06 | 430 | 212 | 13 | 35044719 |
| Pubmed | MAP4 CKAP5 URB2 ARID1A DNTTIP2 DHX8 XPO5 SYNE2 SMARCA5 HNRNPUL1 KHSRP NOP14 GTF3C1 PHF3 SPEN ATP2A2 | 2.97e-06 | 653 | 212 | 16 | 22586326 | |
| Pubmed | 3.00e-06 | 101 | 212 | 7 | 9872452 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | NR2C2 MAP4 TBC1D5 DNTTIP2 ZNF608 TAF9 POLK CPS1 ZHX2 RESF1 PRPF3 PHF3 HELLS | 3.90e-06 | 444 | 212 | 13 | 34795231 |
| Pubmed | VPS45 CKAP5 MYNN ARMCX4 CMYA5 ARID1A RYR3 CYRIA USP32 DGCR8 QKI AKAP6 RAP1GAP SORBS2 VSNL1 ANK3 SYNE1 ITSN1 CLIC4 REV3L HNRNPUL1 MICAL2 ATP2A2 | 4.30e-06 | 1285 | 212 | 23 | 35914814 | |
| Pubmed | TRAF3 GPATCH4 URB2 ARHGEF17 FAT1 XPO5 NFIC SYNE2 QSOX2 MAP7D3 RBBP6 NOA1 CCT4 HNRNPUL1 SLC2A3 NGDN CDC37 GYS1 UGGT2 AKAP13 FTL ATP2A2 HELLS | 5.01e-06 | 1297 | 212 | 23 | 33545068 | |
| Pubmed | Large-scale phosphomimetic screening identifies phospho-modulated motif-based protein interactions. | 5.30e-06 | 110 | 212 | 7 | 37219487 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | BNC2 TRAF3 ARID1A DNAJC6 BBX SVIL USP32 SPATS2 TAF9 SHROOM3 ZNF407 TENM3 LRRC8A CTNND1 | 6.11e-06 | 536 | 212 | 14 | 15840001 |
| Pubmed | BNC2 TRAF3 ARID1A DNAJC6 BBX SVIL USP32 SPATS2 TAF9 SHROOM3 ZNF407 TENM3 LRRC8A CTNND1 | 6.37e-06 | 538 | 212 | 14 | 10512203 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NR2C2 MAP4 RPS6KA3 GPATCH4 ITIH4 DNTTIP2 XPO5 FDFT1 TAF9 PLRG1 SMARCA5 RBBP6 CCT4 IDH3A HNRNPUL1 KHSRP NGDN CDC37 NOP14 UPF2 GYS1 ATP2A2 SNRPD2 | 6.50e-06 | 1318 | 212 | 23 | 30463901 |
| Pubmed | CECR2 is involved in spermatogenesis and forms a complex with SNF2H in the testis. | 7.40e-06 | 21 | 212 | 4 | 22154806 | |
| Pubmed | MAP4 ARID1A GPRIN1 KMT2C SMARCA5 MAP7D3 ANK3 RBBP6 KHSRP SETD2 GTF3C1 PHF3 CTNND1 SPEN | 8.01e-06 | 549 | 212 | 14 | 38280479 | |
| Pubmed | VPS45 TBC1D5 GPRIN1 EHBP1L1 SYNE1 CLIC4 CCT4 HNRNPUL1 CDC37 CD44 CTNND1 | 8.43e-06 | 339 | 212 | 11 | 37232246 | |
| Pubmed | TRAF3 EMC3 VPS45 RPS6KA3 JUND XPO5 FDFT1 SYNE2 MICAL3 DDX60L CCT4 HNRNPUL1 SDAD1 KHSRP CDC37 RAB3GAP1 GTF3C1 PRPF3 AASS EIF2B1 CD44 ATP2A2 SNRPD2 HELLS | 8.70e-06 | 1440 | 212 | 24 | 30833792 | |
| Pubmed | GPATCH4 DHX8 BBX C7orf25 DGCR8 QKI PLRG1 RBBP6 NOA1 HNRNPUL1 SDAD1 NOP14 GTF3C1 UPF2 PRPF3 SNRPD2 | 8.94e-06 | 713 | 212 | 16 | 29802200 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 9.11e-06 | 220 | 212 | 9 | 35785414 | |
| Pubmed | ARHGAP32 SYNPO2 MYH11 MYNN KMT2C ANK3 RBBP6 KIF26B SYNE1 ITSN1 MKNK1 AKAP13 PRKCH | 1.03e-05 | 486 | 212 | 13 | 20936779 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.11e-05 | 123 | 212 | 7 | 26912792 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MAP4 TBC1D5 CKAP5 ARID1A GPRIN1 IVD FDFT1 SYNE2 QKI PLRG1 SMARCA5 CLIC4 CCT4 XPNPEP1 IDH3A HNRNPUL1 SERPINA12 SLC2A3 KHSRP CDC37 CD44 ATP2A2 SNRPD2 | 1.17e-05 | 1367 | 212 | 23 | 32687490 |
| Pubmed | Interaction network of human early embryonic transcription factors. | NR2C2 ARID1A KMT2C ZNF608 NFIB NFIC TSHZ3 SMARCA5 ZHX2 RESF1 SPEN | 1.17e-05 | 351 | 212 | 11 | 38297188 |
| Pubmed | CCP110 ARHGAP32 MYH11 FCHO1 TBC1D9 SPON1 MICAL3 RAP1GAP ZNF407 WDFY4 SETD2 RAB3GAP1 CDK13 | 1.19e-05 | 493 | 212 | 13 | 15368895 | |
| Pubmed | 1.22e-05 | 83 | 212 | 6 | 28794006 | ||
| Pubmed | MYH11 MAP4 RPS6KA3 GPATCH4 SVIL SPATS2 TAF9 QKI PLRG1 CBX2 SMARCA5 VSNL1 SDAD1 KHSRP NGDN UPF2 PHF3 CDK13 EIF2B1 LRRC8A FTL CTNND1 SNRPD2 | 1.22e-05 | 1371 | 212 | 23 | 36244648 | |
| Pubmed | TBC1D5 MICAL3 PLRG1 QSOX2 LRRC41 RAP1GAP NOA1 GTF3C1 UPF2 CDK13 UGGT2 AKAP13 CRYBG3 DHX34 HELLS | 1.24e-05 | 650 | 212 | 15 | 38777146 | |
| Pubmed | CCP110 ZGRF1 ARHGEF17 FER1L6 SENP1 HERC1 SMARCA5 SYNE1 SERPINA12 | 1.49e-05 | 234 | 212 | 9 | 36243803 | |
| Pubmed | 1.50e-05 | 86 | 212 | 6 | 35103284 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | MAP4 RPS6KA3 CKAP5 ARID1A PLRG1 SMARCA5 RBBP6 CLIC4 CCT4 IDH3A KHSRP CDK13 SPEN ATP2A2 SNRPD2 | 1.61e-05 | 665 | 212 | 15 | 30457570 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NR2C2 EMC3 MAP4 HS6ST2 FAT1 FDFT1 SVIL NADK QSOX2 TMEM87A KHSRP CDC37 SNX14 GTF3C1 TENM3 MICAL2 CD44 CD47 LRRC8A UGGT2 ATP2A2 | 1.63e-05 | 1201 | 212 | 21 | 35696571 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | EMC3 TBC1D5 CKAP5 URB2 DNTTIP2 SENP1 ZNF608 XPO5 FDFT1 PLRG1 QSOX2 RBBP6 ZNF407 SDAD1 NOP14 MICAL2 PHF3 CD44 CD47 ZNF525 ATP2A2 | 1.67e-05 | 1203 | 212 | 21 | 29180619 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CCP110 ZGRF1 ARID1A ALDH1A2 TAF9 POLK PLRG1 RBBP6 ITSN1 ZNF507 SETD2 RESF1 CRYBG3 SPEN | 1.72e-05 | 588 | 212 | 14 | 38580884 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EMC3 MAP4 CKAP5 GPATCH4 DNTTIP2 DHX8 RTF1 NFIC SYNE2 SPATS2 PLRG1 SMARCA5 CCT4 HNRNPUL1 CPS1 KHSRP PRPF3 CDK13 AKAP13 CTNND1 ATP2A2 SNRPD2 HELLS | 2.01e-05 | 1415 | 212 | 23 | 28515276 |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 2.36e-05 | 248 | 212 | 9 | 27926873 | |
| Pubmed | ARHGAP32 EMC3 MAP4 VPS45 CKAP5 GPRIN1 KCNJ3 AMPH SORBS2 ANK3 PCLO CCT4 SRCIN1 IDH3A KHSRP RAB3GAP1 CRYBG3 CTNND1 ATP2A2 FAM131B | 2.46e-05 | 1139 | 212 | 20 | 36417873 | |
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 2.60e-05 | 57 | 212 | 5 | 21886157 | |
| Pubmed | 2.60e-05 | 57 | 212 | 5 | 38223760 | ||
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 2.83e-05 | 195 | 212 | 8 | 17110338 | |
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 3.04e-05 | 197 | 212 | 8 | 29872149 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 3.04e-05 | 197 | 212 | 8 | 20811636 | |
| Pubmed | 3.55e-05 | 11 | 212 | 3 | 10441735 | ||
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 3.55e-05 | 11 | 212 | 3 | 20351715 | |
| Pubmed | ARID1A DHX8 RTF1 NFIC ITSN1 CLIC4 SDAD1 CDC37 PHF3 CD44 CRYBG3 CTNND1 | 3.70e-05 | 472 | 212 | 12 | 38943005 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NR2C2 ARID1A KMT2C ZNF608 NFIB SYNE2 TSHZ3 CECR2 PCLO ZHX2 RESF1 | 3.70e-05 | 398 | 212 | 11 | 35016035 |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 23615220 | ||
| Pubmed | On the Role of Histamine Receptors in the Regulation of Circadian Rhythms. | 3.70e-05 | 2 | 212 | 2 | 26660098 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 11792814 | ||
| Pubmed | The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32. | 3.70e-05 | 2 | 212 | 2 | 9171108 | |
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 3.70e-05 | 2 | 212 | 2 | 24931616 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 25892112 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 33368883 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 22450351 | ||
| Pubmed | Neuronal functions, feeding behavior, and energy balance in Slc2a3+/- mice. | 3.70e-05 | 2 | 212 | 2 | 18780771 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 20686835 | ||
| Pubmed | Expression of mouse-GLUT3 and human-GLUT3 glucose transporter proteins in brain. | 3.70e-05 | 2 | 212 | 2 | 1734877 | |
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 31884568 | ||
| Pubmed | 3.70e-05 | 2 | 212 | 2 | 23193055 | ||
| Interaction | ARL16 interactions | 2.37e-06 | 83 | 209 | 8 | int:ARL16 | |
| Interaction | NUP43 interactions | NR2C2 MAP4 GPATCH4 CCDC168 ARID1A DNTTIP2 DHX8 RTF1 FSIP2 SENP1 BBX ZNF608 SYNE2 RBBP6 ICE1 ZHX2 SDAD1 SETD2 NOP14 RESF1 SPEN | 2.38e-06 | 625 | 209 | 21 | int:NUP43 |
| Interaction | SNRNP40 interactions | NR2C2 GPATCH4 ARID1A DNTTIP2 DHX8 SENP1 ZNF608 NFIC QKI PLRG1 CBX2 RBBP6 HNRNPUL1 ZHX2 KHSRP SETD2 NOP14 PRPF3 SPEN SNRPD2 RBM41 | 3.20e-06 | 637 | 209 | 21 | int:SNRNP40 |
| Interaction | DOT1L interactions | NR2C2 ERCC6 CKAP5 GPATCH4 DNTTIP2 DHX8 JUND NFIB NFIC QKI PLRG1 SMARCA5 RBBP6 CCT4 CPS1 SDAD1 NGDN NOP14 GTF3C1 PRPF3 PHF3 CTNND1 ATP2A2 SNRPD2 | 3.64e-06 | 807 | 209 | 24 | int:DOT1L |
| Interaction | H3C1 interactions | NR2C2 ERCC6 RPS6KA3 GPATCH4 GPRIN1 DNTTIP2 KMT2C BBX NFIC TAF9 CBX2 MMS22L SMARCA5 ANK3 SYNE1 SDAD1 SETD2 GTF3C1 PRPF3 PHF3 CDK13 UGGT2 SPEN SNRPD2 HELLS | 7.56e-06 | 901 | 209 | 25 | int:H3C1 |
| Interaction | MEN1 interactions | ERCC6 GPATCH4 ARID1A ARHGEF17 DNTTIP2 DHX8 KMT2C JUND SENP1 ZNF608 NFIB NFIC SPATS2 QKI PLRG1 SMARCA5 RBBP6 SDAD1 KHSRP NOP14 GTF3C1 UPF2 PRPF3 SETBP1 CTNND1 SPEN ATP2A2 | 8.79e-06 | 1029 | 209 | 27 | int:MEN1 |
| Interaction | YWHAH interactions | CCP110 ARHGAP32 MYH11 TBC1D5 RPS6KA3 CKAP5 ARHGEF17 SYDE2 SVIL SYNE2 OSBPL6 NADK HERC1 SHROOM3 RAP1GAP SORBS2 MAP7D3 KIF26B HNRNPUL1 CDC37 C2CD3 RESF1 PHF3 AASS AKAP13 CRYBG3 CTNND1 SNRPD2 | 1.07e-05 | 1102 | 209 | 28 | int:YWHAH |
| Interaction | DDX23 interactions | NR2C2 ERCC6 GPATCH4 DNTTIP2 DHX8 RTF1 RBBP6 SYNE1 WDFY4 SDAD1 SETD2 NOP14 PRPF3 PHF3 CDK13 SNRPD2 HELLS | 1.15e-05 | 480 | 209 | 17 | int:DDX23 |
| Interaction | HECTD1 interactions | ERCC6 MAP4 CKAP5 GPATCH4 URB2 DNTTIP2 DHX8 DGCR8 SPATS2 PLRG1 SMARCA5 SHROOM3 MAP7D3 RBBP6 HNRNPUL1 SDAD1 NGDN MB21D2 NOP14 GTF3C1 UPF2 PRPF3 PHF3 CDK13 EIF2B1 SNRPD2 | 1.16e-05 | 984 | 209 | 26 | int:HECTD1 |
| Interaction | DHX8 interactions | GPATCH4 DHX8 RTF1 TAF9 PLRG1 RBBP6 SETD2 PRPF3 CDK13 SPEN DHX34 SNRPD2 RBM41 | 1.20e-05 | 292 | 209 | 13 | int:DHX8 |
| Interaction | FBXO22 interactions | ERCC6 GPRIN1 RYR3 RTF1 KMT2C USP32 MICAL3 HERC1 PLRG1 SMARCA5 ANK3 SRCIN1 TMEM87A SDAD1 SNX14 GTF3C1 CTNND1 HELLS | 1.44e-05 | 540 | 209 | 18 | int:FBXO22 |
| Interaction | YWHAZ interactions | CCP110 NR2C2 ARHGAP32 SYNPO2 MYH11 HS6ST2 TBC1D5 CKAP5 ARID1A SPATA2 IVD FSIP2 SYDE2 SVIL SYNE2 OSBPL6 NADK SHROOM3 RAP1GAP SORBS2 MAP7D3 KIF26B CLIC4 HNRNPUL1 ZHX2 CDC37 PHF3 AASS AKAP13 CTNND1 ATP2A2 | 1.62e-05 | 1319 | 209 | 31 | int:YWHAZ |
| Interaction | H3C3 interactions | NR2C2 GPATCH4 DNTTIP2 DHX8 FSIP2 BBX ANAPC7 LRRC41 CBX2 TSHZ3 MMS22L SMARCA5 NOP14 GTF3C1 PHF3 SPEN HELLS | 1.71e-05 | 495 | 209 | 17 | int:H3C3 |
| Interaction | ZNF330 interactions | GPATCH4 URB2 DNTTIP2 RTF1 BBX XPO5 LRRC41 CBX2 SMARCA5 RAP1GAP SDAD1 NOP14 GTF3C1 PHF3 ATP2A2 HELLS | 1.80e-05 | 446 | 209 | 16 | int:ZNF330 |
| Interaction | COIL interactions | NR2C2 GPATCH4 DHX8 RTF1 BBX NFIC TAF9 LRRC41 CCT4 ICE1 SDAD1 NOP14 GTF3C1 PRPF3 ATP2A2 SNRPD2 RBM41 HELLS | 1.93e-05 | 552 | 209 | 18 | int:COIL |
| Interaction | PAX2 interactions | 2.90e-05 | 85 | 209 | 7 | int:PAX2 | |
| Interaction | RHOD interactions | ARHGAP32 EMC3 VPS45 TBC1D5 AIF1L GPRIN1 SENP1 EHBP1L1 SEMA6D XPO5 SYNE2 ANK3 KIF26B TMEM87A RAB3GAP1 CD44 LRRC8A CTNND1 | 3.08e-05 | 572 | 209 | 18 | int:RHOD |
| Interaction | MYCN interactions | SYNPO2 GPATCH4 ARID1A DNTTIP2 BBX DGCR8 SPATS2 QKI PLRG1 SMARCA5 SHROOM3 RBBP6 NOA1 SYNE1 CCT4 HNRNPUL1 SDAD1 KHSRP NGDN SETD2 NOP14 GTF3C1 UPF2 PRPF3 MICAL2 PHF3 CDK13 ELAVL3 AKAP13 ATP2A2 SNRPD2 | 3.50e-05 | 1373 | 209 | 31 | int:MYCN |
| Interaction | FOXL1 interactions | NR2C2 CKAP5 KMT2C ZNF608 NFIB NFIC TAF9 SMARCA5 GTF3C1 HELLS | 3.97e-05 | 196 | 209 | 10 | int:FOXL1 |
| Interaction | TLE3 interactions | NR2C2 MYH8 ARID1A JUND ZNF608 NFIB NFIC QKI TSHZ3 ANK3 RBBP6 CECR2 SETD2 SPEN | 4.06e-05 | 376 | 209 | 14 | int:TLE3 |
| Interaction | KCTD13 interactions | ARHGAP32 MYH11 MAP4 VPS45 CKAP5 ARID1A ARHGEF17 DNAJC6 SPON1 SVIL OSBPL6 MICAL3 AMPH RAP1GAP SORBS2 ANK3 SYNE1 PCLO ITSN1 CCT4 SRCIN1 IDH3A SLC2A3 KHSRP CDC37 UPF2 MICAL2 ELAVL3 CTNND1 ATP2A2 SNRPD2 | 4.66e-05 | 1394 | 209 | 31 | int:KCTD13 |
| Interaction | FEV interactions | 5.35e-05 | 203 | 209 | 10 | int:FEV | |
| Interaction | PAX9 interactions | 6.44e-05 | 130 | 209 | 8 | int:PAX9 | |
| Interaction | RHOB interactions | ARHGAP32 VPS45 GPRIN1 FAT1 SEMA6D USP32 OSBPL6 MICAL3 HERC1 SHROOM3 ANK3 KIF26B ITSN1 SLC2A14 CCT4 TMEM87A TENM3 CD44 LRRC8A AKAP13 PRKCH CTNND1 | 6.51e-05 | 840 | 209 | 22 | int:RHOB |
| Interaction | TERF2IP interactions | GPATCH4 ARID1A DHX8 RTF1 BBX ZNF608 DGCR8 TAF9 CBX2 RBBP6 ZNF507 SETD2 GTF3C1 PHF3 CDK13 SPEN HELLS | 6.70e-05 | 552 | 209 | 17 | int:TERF2IP |
| Interaction | FGFBP1 interactions | GPATCH4 URB2 BBX DGCR8 SPATS2 SMARCA5 SDAD1 NGDN NOP14 GTF3C1 CDK13 | 8.10e-05 | 257 | 209 | 11 | int:FGFBP1 |
| Interaction | C2CD4B interactions | 8.94e-05 | 44 | 209 | 5 | int:C2CD4B | |
| Interaction | H3-3A interactions | NR2C2 ERCC6 RPS6KA3 CKAP5 DNTTIP2 DHX8 KMT2C BBX NFIC POLK ANAPC7 LRRC41 CBX2 TSHZ3 SMARCA5 NOP14 GTF3C1 PHF3 SPEN HELLS | 1.09e-04 | 749 | 209 | 20 | int:H3-3A |
| Interaction | SFN interactions | CCP110 ARHGAP32 MYH11 MAP4 TBC1D5 ARHGEF17 NFIB NFIC SVIL NADK SHROOM3 RAP1GAP SORBS2 MAP7D3 KIF26B PHF3 AASS AKAP13 CRYBG3 | 1.14e-04 | 692 | 209 | 19 | int:SFN |
| Interaction | SMC5 interactions | NR2C2 MAP4 GPATCH4 ARID1A DNTTIP2 BBX DGCR8 TAF9 PLRG1 CBX2 SMARCA5 MAP7D3 RBBP6 ICE1 REV3L HNRNPUL1 KHSRP SETD2 PRPF3 PHF3 SPEN ATP2A2 SNRPD2 HELLS | 1.16e-04 | 1000 | 209 | 24 | int:SMC5 |
| Interaction | LHX2 interactions | 1.28e-04 | 183 | 209 | 9 | int:LHX2 | |
| Interaction | PRPF4 interactions | NR2C2 ERCC6 MAP4 SYNE2 DGCR8 PLRG1 SMARCA5 CCT4 CDC37 PRPF3 SNRPD2 | 1.30e-04 | 271 | 209 | 11 | int:PRPF4 |
| Interaction | ZBTB38 interactions | 1.38e-04 | 145 | 209 | 8 | int:ZBTB38 | |
| Interaction | PAX8 interactions | 1.59e-04 | 111 | 209 | 7 | int:PAX8 | |
| Interaction | CENPA interactions | ERCC6 GPATCH4 DNTTIP2 RTF1 BBX LRRC41 CBX2 TSHZ3 SMARCA5 SDAD1 NOP14 GTF3C1 HELLS | 1.65e-04 | 377 | 209 | 13 | int:CENPA |
| Interaction | IFI16 interactions | CKAP5 GPATCH4 URB2 DNTTIP2 DHX8 CIITA SVIL DDX60L SPATS2 PLRG1 SMARCA5 SYNE1 HNRNPUL1 SDAD1 NGDN NOP14 PRPF3 EIF2B1 CTNND1 | 1.71e-04 | 714 | 209 | 19 | int:IFI16 |
| Interaction | POLR1G interactions | NR2C2 GPATCH4 URB2 DNTTIP2 RTF1 BBX XPO5 CBX2 ICE1 SDAD1 NOP14 GTF3C1 PHF3 ATP2A2 HELLS | 1.89e-04 | 489 | 209 | 15 | int:POLR1G |
| Interaction | ATXN1 interactions | ARHGAP32 MAP4 TBC1D5 RPS6KA3 CKAP5 ARID1A NFIB NFIC SYNE2 QKI PLRG1 SMARCA5 VSNL1 RBBP6 CLIC4 CCT4 IDH3A ZHX2 KHSRP SETD2 CDK13 SPEN ATP2A2 SNRPD2 | 2.06e-04 | 1039 | 209 | 24 | int:ATXN1 |
| Interaction | SOX7 interactions | 2.11e-04 | 82 | 209 | 6 | int:SOX7 | |
| Interaction | CIT interactions | ARHGAP32 MYH11 CKAP5 GPATCH4 CMYA5 ITIH4 DNTTIP2 DHX8 XPO5 SVIL SYNE2 DDX60L HERC1 ANAPC7 PLRG1 SMARCA5 SORBS2 RBBP6 SYNE1 PCLO CCT4 HNRNPUL1 CPS1 KHSRP NOP14 PRPF3 CD44 CTNND1 ATP2A2 SNRPD2 | 2.24e-04 | 1450 | 209 | 30 | int:CIT |
| Interaction | CDC5L interactions | NR2C2 CKAP5 ARID1A DHX8 XPO5 ANAPC7 PLRG1 AKAP6 SMARCA5 SHROOM3 RBBP6 SYNE1 CCT4 SDAD1 NOP14 PRPF3 CD44 CTNND1 SPEN SNRPD2 HELLS | 2.32e-04 | 855 | 209 | 21 | int:CDC5L |
| Interaction | PARP1 interactions | NR2C2 ERCC6 GPATCH4 URB2 DNTTIP2 RTF1 SENP1 BBX NFIB NFIC SVIL DGCR8 ANAPC7 CBX2 SMARCA5 CECR2 CLIC4 HNRNPUL1 SDAD1 CDC37 NOP14 GTF3C1 PHF3 AASS CDK13 ATP2A2 SNRPD2 HELLS | 2.35e-04 | 1316 | 209 | 28 | int:PARP1 |
| Interaction | SMARCA2 interactions | NR2C2 ERCC6 ARID1A DNTTIP2 CIITA NFIB NFIC TAF9 SMARCA5 NECAB2 REV3L KHSRP | 2.78e-04 | 346 | 209 | 12 | int:SMARCA2 |
| Interaction | POC1A interactions | 2.85e-04 | 122 | 209 | 7 | int:POC1A | |
| Interaction | MAGEB2 interactions | GPATCH4 URB2 DNTTIP2 DHX8 BBX DGCR8 SPATS2 SMARCA5 RBBP6 NOA1 SDAD1 CDK13 | 3.01e-04 | 349 | 209 | 12 | int:MAGEB2 |
| Interaction | APEX1 interactions | TMEM126B GPATCH4 FCHO1 DNTTIP2 RTF1 CCDC66 BBX SEMA6D NFIC POLK QKI LRRC41 CBX2 RAP1GAP ITSN1 HNRNPUL1 SDAD1 CDC37 SNX14 SETD2 NOP14 GTF3C1 PHF3 AASS CDK13 CD44 HELLS | 3.14e-04 | 1271 | 209 | 27 | int:APEX1 |
| Interaction | PAX7 interactions | 3.15e-04 | 124 | 209 | 7 | int:PAX7 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 5.60e-05 | 29 | 132 | 4 | 396 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.33e-04 | 36 | 132 | 4 | 823 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 3.14e-04 | 4 | 132 | 2 | 1252 | |
| GeneFamily | Histamine receptors | 3.14e-04 | 4 | 132 | 2 | 187 | |
| GeneFamily | EF-hand domain containing | 1.14e-03 | 219 | 132 | 7 | 863 | |
| GeneFamily | ATPases Ca2+ transporting | 1.84e-03 | 9 | 132 | 2 | 1209 | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 2.79e-03 | 11 | 132 | 2 | 1156 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RPS6KA3 CKAP5 FAT1 BBX NFIB SYNE2 MICAL3 QKI AMPH SMARCA5 ITSN1 REV3L ZHX2 TMEM87A SETD2 RAB3GAP1 C2CD3 UPF2 MICAL2 PHF3 CDK13 AKAP13 CRYBG3 SPEN | 1.23e-07 | 856 | 211 | 24 | M4500 |
| Coexpression | GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP | ZDHHC2 CYRIA EHBP1L1 POLK XDH SRCIN1 RGS1 SLC2A3 MICAL2 CD44 | 8.72e-07 | 163 | 211 | 10 | M6329 |
| Coexpression | TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C | ARHGAP32 VPS45 TBC1D5 ARID1A XPO5 SYNE2 ANAPC7 MMS22L RAP1GAP HNRNPUL1 SETD2 UPF2 UGGT2 ATP2A2 BORA HELLS | 9.50e-07 | 454 | 211 | 16 | M19927 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CKAP5 FAT1 BBX NFIB MICAL3 QKI ITSN1 REV3L ZHX2 SETD2 RAB3GAP1 C2CD3 UPF2 PHF3 CDK13 SPEN | 1.33e-06 | 466 | 211 | 16 | M13522 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.75e-06 | 176 | 211 | 10 | M39223 | |
| Coexpression | GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP | HS6ST2 CMYA5 PHKA1 SLC22A14 CBX2 TSHZ3 AMPH CREBL2 ALX1 AASS | 5.50e-06 | 200 | 211 | 10 | M8436 |
| Coexpression | GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP | 1.49e-05 | 178 | 211 | 9 | M6326 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.63e-05 | 180 | 211 | 9 | M8239 | |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 2.39e-05 | 145 | 211 | 8 | M1810 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MYO1G RPS6KA3 ARID1A DNTTIP2 PCNX2 KMT2C JUND BBX HERC1 QKI SMARCA5 MAP7D3 RBBP6 SYNE1 CCT4 ICE1 REV3L RGS1 SLC2A3 SETD2 RESF1 PHF3 CDK13 CD44 CD47 AKAP13 PRKCH SPEN | 2.72e-05 | 1492 | 211 | 28 | M40023 |
| Coexpression | LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN | NR2C2 ARHGAP32 TBC1D5 TMEM126B ZKSCAN7 ARID1A ARHGEF17 DNAJC6 CCDC66 NADK FGR LRRC41 CLIC4 XPNPEP1 MKNK1 SETD2 C2CD3 NOP14 SPEN | 3.14e-05 | 807 | 211 | 19 | M14594 |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP | 3.46e-05 | 198 | 211 | 9 | M5215 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH2_UP | 3.46e-05 | 198 | 211 | 9 | M5455 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP | 3.74e-05 | 200 | 211 | 9 | M8469 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 6.17e-05 | 265 | 211 | 10 | M1684 | |
| Coexpression | CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN | 6.82e-05 | 168 | 211 | 8 | M45039 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 6.97e-05 | 86 | 211 | 6 | M39248 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 7.67e-05 | 272 | 211 | 10 | MM1027 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | VPS45 TBC1D5 RPS6KA3 DNTTIP2 RYR3 CYRIA C7orf25 FDFT1 SYNE2 NADK QKI SMARCA5 VSNL1 MAP7D3 RBBP6 CCT4 RGS1 CREBL2 UPF2 CDK13 EIF2B1 ATP2A2 RBM41 | 1.32e-04 | 1215 | 211 | 23 | M41122 |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | IVD JUND CCDC66 BBX ANK3 RBBP6 ZNF507 RGS1 PABIR3 NGDN PRPF3 PHF3 CD44 | 1.33e-04 | 474 | 211 | 13 | M40991 |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 1.71e-04 | 244 | 211 | 9 | M40312 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.71e-04 | 300 | 211 | 10 | M8702 | |
| Coexpression | GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 1.91e-04 | 195 | 211 | 8 | M7926 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH2_UP | 1.91e-04 | 195 | 211 | 8 | M5424 | |
| Coexpression | GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP | 1.98e-04 | 196 | 211 | 8 | M5862 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP | MAP4 TMEM126B EHBP1L1 CIITA NADK DDX60L FGR POLK QKI IDH3A CREBL2 RAB3GAP1 CDK13 CTNND1 | 2.00e-04 | 562 | 211 | 14 | M41008 |
| Coexpression | GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP | 2.12e-04 | 198 | 211 | 8 | M5856 | |
| Coexpression | GSE3982_MAC_VS_NKCELL_DN | 2.12e-04 | 198 | 211 | 8 | M5509 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 2.12e-04 | 198 | 211 | 8 | M3171 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN | 2.20e-04 | 199 | 211 | 8 | M3583 | |
| Coexpression | GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN | 2.20e-04 | 199 | 211 | 8 | M9959 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP | 2.20e-04 | 199 | 211 | 8 | M6638 | |
| Coexpression | GSE40273_XBP1_KO_VS_WT_TREG_DN | 2.20e-04 | 199 | 211 | 8 | M9124 | |
| Coexpression | GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN | 2.27e-04 | 200 | 211 | 8 | M3510 | |
| Coexpression | GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN | 2.27e-04 | 200 | 211 | 8 | M7230 | |
| Coexpression | GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN | 2.27e-04 | 200 | 211 | 8 | M6417 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 2.27e-04 | 200 | 211 | 8 | M6477 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP | 2.27e-04 | 200 | 211 | 8 | M7808 | |
| Coexpression | GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP | 2.27e-04 | 200 | 211 | 8 | M9261 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | BNC2 SYNPO2 RPS6KA3 CKAP5 ARID1A ARHGEF17 PHKA1 ALDH1A2 CCDC66 NFIB FDFT1 NFIC SVIL RTL9 RAP1GAP KIF26B SYNE1 REV3L ALX1 LRRC8A MPC1 AKAP13 | 4.61e-06 | 744 | 209 | 22 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_200 | 8.63e-06 | 29 | 209 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#3_top-relative-expression-ranked_200 | 1.67e-05 | 33 | 209 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k3_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | BNC2 NR2C2 MYH8 MAP4 HS6ST2 AIF1L PCNX2 KMT2C BBX SEMA6D NFIB SYNE2 HERC1 SMARCA5 SORBS2 VSNL1 ASZ1 RESF1 CD44 UGGT2 HELLS | 4.08e-05 | 795 | 209 | 21 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | CCP110 HS6ST2 RPS6KA3 SENP1 ALDH1A2 ZNF608 AMPH SHROOM3 SORBS2 ZCWPW1 RBBP6 KIF26B CECR2 PCLO CLIC4 ZHX2 TENM3 SETBP1 CD47 CRYBG3 | 5.40e-05 | 749 | 209 | 20 | gudmap_kidney_P3_CapMes_Crym_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | ZDHHC2 ARHGAP42 BNC2 MYH11 VPS45 HS6ST2 FAT1 ALDH1A2 NFIB FDFT1 KCNJ3 SVIL SYNE2 VSNL1 ZCWPW1 KIF26B REV3L TENM3 MICAL2 GYS1 | 8.32e-05 | 773 | 209 | 20 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZDHHC2 CCP110 ZGRF1 TBC1D5 ARID1A DHX8 SYNE2 USP32 TAF9 QKI PCLO ZNF507 ZNF407 HNRNPUL1 GTF3C1 UPF2 MICAL2 | 8.89e-05 | 595 | 209 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | HS6ST2 RPS6KA3 ALDH1A2 AMPH SHROOM3 ZCWPW1 KIF26B ZHX2 TENM3 SETBP1 | 1.22e-04 | 236 | 209 | 10 | gudmap_kidney_P3_CapMes_Crym_k1_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | BNC2 NR2C2 MYH11 MAP4 AIF1L ALDH1A2 NFIB SYNE2 HERC1 SORBS2 RESF1 CD44 HELLS | 1.95e-04 | 404 | 209 | 13 | gudmap_developingGonad_e18.5_epididymis_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#2_top-relative-expression-ranked_200 | 2.04e-04 | 30 | 209 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#2_top-relative-expression-ranked_500 | 2.07e-04 | 86 | 209 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Podocyte cells_emap-27915_k-means-cluster#5_top-relative-expression-ranked_500 | 2.07e-04 | 86 | 209 | 6 | gudmap_developingKidney_e15.5_Podocyte cells_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274 | 2.36e-04 | 256 | 209 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | ZDHHC2 SYNPO2 MYH11 RPS6KA3 MYNN RYR3 CYRIA EHBP1L1 NFIB SPON1 OSBPL6 TSHZ3 SYNE1 REV3L C2CD3 ALX1 CD44 CD47 BORA | 2.38e-04 | 772 | 209 | 19 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.49e-04 | 89 | 209 | 6 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | ZDHHC2 ARHGAP42 BNC2 MYH11 HS6ST2 ZGRF1 ARMCX4 COLEC11 CYRIA ALDH1A2 NFIB KCNJ3 SVIL VSNL1 ZCWPW1 KIF26B REV3L TENM3 MICAL2 | 2.58e-04 | 777 | 209 | 19 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#4_top-relative-expression-ranked_500 | 2.81e-04 | 91 | 209 | 6 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | ZDHHC2 ARHGAP42 BNC2 MYH8 MYH11 HS6ST2 RPS6KA3 ALDH1A2 SEMA6D NFIB SYNE2 SORBS2 VSNL1 ZCWPW1 REV3L ALX1 RESF1 TENM3 GYS1 | 2.84e-04 | 783 | 209 | 19 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | CMYA5 FAT1 ANKRD2 SVIL ALPK3 MICAL3 DDX60L QKI AKAP6 SORBS2 ANK3 AKAP13 ATP2A2 | 8.32e-12 | 190 | 212 | 13 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | BNC2 ZNF608 NFIB SYNE2 HRH1 MICAL3 NPAS2 SHROOM3 SORBS2 ANK3 KIF26B | 1.63e-09 | 186 | 212 | 11 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | CMYA5 ANKRD2 SVIL ALPK3 MICAL3 QKI AKAP6 SORBS2 ANK3 AKAP13 ATP2A2 | 1.93e-09 | 189 | 212 | 11 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ARHGAP42 BNC2 SYNPO2 MYH11 FAT1 SEMA6D NFIB SPON1 SLC30A10 AMPH VSNL1 | 2.28e-09 | 192 | 212 | 11 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | RPS6KA3 SVIL HRH1 NPAS2 ZHX2 SLC2A3 MB21D2 TENM3 MICAL2 CD44 AKAP13 | 2.28e-09 | 192 | 212 | 11 | 8b86db2ebe0199fee0e9800566a619a24bfdeed5 |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | RTF1 KCNJ3 HERC1 AMPH SORBS2 VSNL1 ANK3 SYNE1 PCLO MICAL2 SETBP1 | 3.49e-09 | 200 | 212 | 11 | 48d801219bc771d6c7e151dc88ca4c179988de85 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | KMT2C JUND SYNE2 DDX60L QKI SMARCA5 SETD2 RESF1 PHF3 CDK13 AKAP13 | 3.49e-09 | 200 | 212 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | DNTTIP2 KMT2C JUND SYNE2 RBBP6 SLC2A3 SETD2 RESF1 PHF3 CDK13 AKAP13 | 3.49e-09 | 200 | 212 | 11 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CCP110 MYH11 AIF1L SCEL ARHGEF17 COLEC11 FAT1 VSNL1 MAP7D3 ZNF507 | 1.94e-08 | 183 | 212 | 10 | 0e8fb371d8eac777451c76f41d53577f5dfb740d |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | CCP110 MYH11 AIF1L SCEL ARHGEF17 COLEC11 FAT1 VSNL1 MAP7D3 ZNF507 | 1.94e-08 | 183 | 212 | 10 | cbc3b00faa7e4e0dbbbc8ee105467c65241c7470 |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.04e-08 | 184 | 212 | 10 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ARHGAP42 SYNPO2 MYH11 RYR3 FAT1 SEMA6D SPON1 HRH1 KIF26B MICAL2 | 2.15e-08 | 185 | 212 | 10 | e58a009aaf342be019a909747b1895d5987d4daf |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | ARHGAP42 BNC2 SYNPO2 MYH11 FAT1 SEMA6D NFIB SPON1 SLC30A10 VSNL1 | 2.64e-08 | 189 | 212 | 10 | 44e37f88137bb249933eb615235b2cf2ae7f3925 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | SYNPO2 CMYA5 SVIL MICAL3 QKI AKAP6 SORBS2 ANK3 AKAP13 ATP2A2 | 2.77e-08 | 190 | 212 | 10 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-08 | 158 | 212 | 9 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-08 | 158 | 212 | 9 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.97e-07 | 187 | 212 | 9 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.10e-07 | 188 | 212 | 9 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.25e-07 | 189 | 212 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-07 | 190 | 212 | 9 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 3.39e-07 | 190 | 212 | 9 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.55e-07 | 191 | 212 | 9 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.55e-07 | 191 | 212 | 9 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-07 | 191 | 212 | 9 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.71e-07 | 192 | 212 | 9 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.71e-07 | 192 | 212 | 9 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.87e-07 | 193 | 212 | 9 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 4.04e-07 | 194 | 212 | 9 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 4.04e-07 | 194 | 212 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 4.22e-07 | 195 | 212 | 9 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.22e-07 | 195 | 212 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | CF-Myeloid|CF / Disease state, Lineage and Cell class | 4.22e-07 | 195 | 212 | 9 | ecf604de496f389a49429d0bb211e1db6019cc8b | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 4.22e-07 | 195 | 212 | 9 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.22e-07 | 195 | 212 | 9 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.22e-07 | 195 | 212 | 9 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 4.41e-07 | 196 | 212 | 9 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 4.41e-07 | 196 | 212 | 9 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.80e-07 | 198 | 212 | 9 | c9c96066c7fa897b583657f0b77ea093920ae9ba | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-07 | 198 | 212 | 9 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-07 | 198 | 212 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-07 | 198 | 212 | 9 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.80e-07 | 198 | 212 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.01e-07 | 199 | 212 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.22e-07 | 200 | 212 | 9 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-06 | 162 | 212 | 8 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.36e-06 | 166 | 212 | 8 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-06 | 167 | 212 | 8 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-06 | 173 | 212 | 8 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 173 | 212 | 8 | c63a615998d13b1725b5767f4ad2ec7e2b61db68 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.98e-06 | 122 | 212 | 7 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.29e-06 | 178 | 212 | 8 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-06 | 178 | 212 | 8 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 179 | 212 | 8 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 179 | 212 | 8 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.48e-06 | 180 | 212 | 8 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 181 | 212 | 8 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-06 | 181 | 212 | 8 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.70e-06 | 182 | 212 | 8 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 184 | 212 | 8 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.04e-06 | 185 | 212 | 8 | a6cd90f8f30c7bdf66958cf403e73c193aa32f5e | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.04e-06 | 185 | 212 | 8 | 5053f932e2adfcf4d6faaecff2999ac53d8d7aa5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.04e-06 | 185 | 212 | 8 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 185 | 212 | 8 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 185 | 212 | 8 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-06 | 186 | 212 | 8 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.30e-06 | 187 | 212 | 8 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-06 | 187 | 212 | 8 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.43e-06 | 188 | 212 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.71e-06 | 190 | 212 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-06 | 191 | 212 | 8 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-06 | 191 | 212 | 8 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.86e-06 | 191 | 212 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.86e-06 | 191 | 212 | 8 | 23776c7302cead3881b39127398f3b3e0d27885e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.01e-06 | 192 | 212 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-06 | 194 | 212 | 8 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.49e-06 | 195 | 212 | 8 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 4.49e-06 | 195 | 212 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.49e-06 | 195 | 212 | 8 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.49e-06 | 195 | 212 | 8 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.66e-06 | 196 | 212 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.84e-06 | 197 | 212 | 8 | 49689a03ab31e53386dbe15c77c09ca3a14ebf4e | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.03e-06 | 198 | 212 | 8 | 2d0c14f8cabab99bc6d7c27685437c78841c7245 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.03e-06 | 198 | 212 | 8 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-06 | 199 | 212 | 8 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.22e-06 | 199 | 212 | 8 | aacd3ffa40a6e6f435aa9be5b959d88812eb69d4 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.22e-06 | 199 | 212 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.22e-06 | 199 | 212 | 8 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.41e-06 | 200 | 212 | 8 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | 593bf6a7c557437db9a9249a5058a46014179ef6 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.41e-06 | 200 | 212 | 8 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.41e-06 | 200 | 212 | 8 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.41e-06 | 200 | 212 | 8 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.41e-06 | 200 | 212 | 8 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 4.01e-05 | 50 | 138 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 9.41e-07 | 178 | 212 | 11 | 3998_DN | |
| Drug | Fluspirilen [1841-19-6]; Up 200; 8.4uM; HL60; HT_HG-U133A | BNC2 ARID1A TBC1D9 JUND ANKRD2 DGCR8 VSNL1 ZCWPW1 ANK3 KIF26B PCLO | 2.08e-06 | 193 | 212 | 11 | 3086_UP |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.93e-06 | 178 | 212 | 10 | 1471_DN | |
| Drug | 2,4,6-triphenyl-1-hexene | 7.85e-06 | 5 | 212 | 3 | ctd:C533342 | |
| Disease | gamma-aminobutyric acid receptor-associated protein-like 1 measurement | 3.13e-06 | 5 | 202 | 3 | EFO_0801613 | |
| Disease | bone measurement, fat body mass, lean body mass | 1.08e-05 | 7 | 202 | 3 | EFO_0004512, EFO_0004995, EFO_0005409 | |
| Disease | non-alcoholic fatty liver disease, cirrhosis of liver | 3.14e-05 | 53 | 202 | 5 | EFO_0001422, EFO_0003095 | |
| Disease | bipolar I disorder | 5.53e-05 | 141 | 202 | 7 | EFO_0009963 | |
| Disease | serum albumin measurement | CYP1A2 TRAF3 MAP4 SLC28A3 EHBP1L1 ALDH1A2 BBX CIITA RTL9 MICAL3 QSOX2 SHROOM3 SERPINA12 CD44 | 6.37e-05 | 592 | 202 | 14 | EFO_0004535 |
| Disease | bitter non-alcoholic beverage consumption measurement | 6.60e-05 | 32 | 202 | 4 | EFO_0010093 | |
| Disease | decanoylcarnitine measurement | 6.64e-05 | 12 | 202 | 3 | EFO_0021039 | |
| Disease | coronary artery disease | ARHGAP42 CYP1A2 TDRD15 MYH11 SPATA2 FCHO1 ITIH4 RTF1 COLEC11 SENP1 EHBP1L1 ALDH1A2 NFIB SHROOM3 SORBS2 ASZ1 MAP7D3 NOA1 HNRNPUL1 AKAP13 SNRPD2 | 7.72e-05 | 1194 | 202 | 21 | EFO_0001645 |
| Disease | cataract (biomarker_via_orthology) | 8.59e-05 | 13 | 202 | 3 | DOID:83 (biomarker_via_orthology) | |
| Disease | Replication Error Phenotype | 1.35e-04 | 15 | 202 | 3 | C1721098 | |
| Disease | Microsatellite Instability | 1.35e-04 | 15 | 202 | 3 | C0920269 | |
| Disease | Drug habituation | 1.45e-04 | 115 | 202 | 6 | C0013170 | |
| Disease | Drug abuse | 1.45e-04 | 115 | 202 | 6 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.45e-04 | 115 | 202 | 6 | C4316881 | |
| Disease | Substance-Related Disorders | 1.45e-04 | 115 | 202 | 6 | C0236969 | |
| Disease | Drug Use Disorders | 1.45e-04 | 115 | 202 | 6 | C0013222 | |
| Disease | Drug Dependence | 1.45e-04 | 115 | 202 | 6 | C1510472 | |
| Disease | Substance Dependence | 1.45e-04 | 115 | 202 | 6 | C0038580 | |
| Disease | Substance Use Disorders | 1.45e-04 | 115 | 202 | 6 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.45e-04 | 115 | 202 | 6 | C0029231 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 1.47e-04 | 346 | 202 | 10 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | Substance abuse problem | 1.52e-04 | 116 | 202 | 6 | C0740858 | |
| Disease | platelet component distribution width | MYO1G CYP1A2 TBC1D5 CYRIA SVIL HERC1 POLK QKI NPAS2 ZCWPW1 SYNE1 CLIC4 CPS1 SETD2 AKAP13 | 2.37e-04 | 755 | 202 | 15 | EFO_0007984 |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 2.77e-04 | 4 | 202 | 2 | cv:CN293514 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 2.77e-04 | 4 | 202 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Intellectual Disability | KMT2C NFIB FDFT1 QKI AKAP6 MAP7D3 SYNE1 SNX14 SETD2 AASS SETBP1 | 2.79e-04 | 447 | 202 | 11 | C3714756 |
| Disease | vital capacity | FAM184B BNC2 SLC28A3 IVD SENP1 RTL9 OSBPL6 NADK MICAL3 QSOX2 VWA5B1 MMS22L SHROOM3 SYNE1 PCLO C16orf96 ZHX2 NOP14 ALX1 ATP2A2 | 3.42e-04 | 1236 | 202 | 20 | EFO_0004312 |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.03e-04 | 139 | 202 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 4.60e-04 | 5 | 202 | 2 | C1450051 | |
| Disease | Cerebellar Ataxia | 4.60e-04 | 5 | 202 | 2 | C0007758 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 4.60e-04 | 5 | 202 | 2 | C0410190 | |
| Disease | Klatskin's tumor (is_implicated_in) | 4.60e-04 | 5 | 202 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | testosterone measurement | FAM184B HS6ST2 SLC28A3 ARID1A IVD BBX SEMA6D SYNE2 RTL9 SHROOM3 VSNL1 ZCWPW1 ANK3 UGT1A6 CECR2 XDH C16orf96 CREBL2 GYS1 SNRPD2 | 5.07e-04 | 1275 | 202 | 20 | EFO_0004908 |
| Disease | serum gamma-glutamyl transferase measurement | TRAF3 RPS6KA3 SLC28A3 ARID1A FCHO1 COLEC11 ALDH1A2 SEMA6D NFIB SVIL MICAL3 SORBS2 UGT1A6 CPS1 SETD2 AKAP13 | 5.93e-04 | 914 | 202 | 16 | EFO_0004532 |
| Disease | smoking behavior | 6.07e-04 | 341 | 202 | 9 | EFO_0004318 | |
| Disease | Adenoid Cystic Carcinoma | 6.36e-04 | 100 | 202 | 5 | C0010606 | |
| Disease | Emery-Dreifuss muscular dystrophy | 6.87e-04 | 6 | 202 | 2 | cv:C0410189 | |
| Disease | glucagon measurement, glucose tolerance test | 6.87e-04 | 6 | 202 | 2 | EFO_0004307, EFO_0008463 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 6.87e-04 | 6 | 202 | 2 | C0410189 | |
| Disease | Weight Gain | 6.96e-04 | 102 | 202 | 5 | C0043094 | |
| Disease | unipolar depression, bipolar disorder | 7.41e-04 | 156 | 202 | 6 | EFO_0003761, MONDO_0004985 | |
| Disease | Abnormality of refraction | ARHGAP32 CCDC66 ZNF608 QKI SLC30A10 QSOX2 AKAP6 TSHZ3 ANK3 PCLO FRMPD2 CD47 AKAP13 | 7.98e-04 | 673 | 202 | 13 | HP_0000539 |
| Disease | cleft lip | 8.00e-04 | 284 | 202 | 8 | EFO_0003959 | |
| Disease | serum metabolite measurement | CYP1A2 TDRD15 CKAP5 SLC28A3 IVD ALDH1A2 SYNE2 BHMT2 DGCR8 SORBS2 KIF26B UGT1A6 REV3L CPS1 UGT1A1 TENM3 | 8.44e-04 | 945 | 202 | 16 | EFO_0005653 |
| Disease | gallstones | 9.01e-04 | 108 | 202 | 5 | EFO_0004210 | |
| Disease | reticulocyte count | ARHGAP42 MYO1G BNC2 FAT1 SENP1 FDFT1 NFIC SYNE2 USP32 NADK HERC1 QKI SLC30A10 RAP1GAP ZHX2 MICAL2 SETBP1 | 9.04e-04 | 1045 | 202 | 17 | EFO_0007986 |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 9.30e-04 | 224 | 202 | 7 | EFO_0004530, EFO_0008317 | |
| Disease | Developmental Psychomotor Disorders | 9.57e-04 | 7 | 202 | 2 | C0751456 | |
| Disease | amino acid measurement, threonine measurement | 9.57e-04 | 7 | 202 | 2 | EFO_0005134, EFO_0009775 | |
| Disease | Psychomotor Disorders | 9.57e-04 | 7 | 202 | 2 | C0033922 | |
| Disease | platelet reactivity measurement, thrombus formation measurement | 9.57e-04 | 7 | 202 | 2 | EFO_0004985, EFO_0007615 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 9.57e-04 | 7 | 202 | 2 | C0751337 | |
| Disease | Bilateral Wilms Tumor | 1.01e-03 | 29 | 202 | 3 | C2930471 | |
| Disease | Neural Tube Defects | 1.12e-03 | 30 | 202 | 3 | C0027794 | |
| Disease | response to dolutegravir | 1.12e-03 | 30 | 202 | 3 | EFO_0600017 | |
| Disease | hair colour measurement | ARHGAP42 BNC2 SCEL ARID1A SEMA6D SYNE2 SHROOM3 REV3L RGS1 SETBP1 CD44 AKAP13 | 1.16e-03 | 615 | 202 | 12 | EFO_0007822 |
| Disease | Colorectal Carcinoma | ZDHHC2 CYP1A2 ERCC6 HTR3C ARID1A KMT2C FAT1 HRH1 QKI AKAP6 SYNE1 FRMPD2 SETBP1 | 1.17e-03 | 702 | 202 | 13 | C0009402 |
| Disease | blood urea nitrogen measurement | CYP1A2 SYNPO2 DHX8 HRH1 SHROOM3 CPS1 SETBP1 UGGT2 AKAP13 DHX34 | 1.18e-03 | 452 | 202 | 10 | EFO_0004741 |
| Disease | household income | 1.24e-03 | 304 | 202 | 8 | EFO_0009695 | |
| Disease | Leukemia, Myelocytic, Acute | 1.27e-03 | 173 | 202 | 6 | C0023467 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 1.27e-03 | 8 | 202 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | plasma clozapine measurement | 1.27e-03 | 8 | 202 | 2 | EFO_0600038 | |
| Disease | Embryonal Rhabdomyosarcoma | 1.27e-03 | 8 | 202 | 2 | C0206656 | |
| Disease | intelligence, self reported educational attainment | 1.29e-03 | 117 | 202 | 5 | EFO_0004337, EFO_0004784 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.50e-03 | 121 | 202 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | velopharyngeal dysfunction | 1.55e-03 | 122 | 202 | 5 | EFO_0009336 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 1.62e-03 | 34 | 202 | 3 | EFO_0008317, EFO_0008596, EFO_0020944 | |
| Disease | X-11442 measurement | 1.63e-03 | 9 | 202 | 2 | EFO_0021236 | |
| Disease | X-11441 measurement | 1.63e-03 | 9 | 202 | 2 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 1.63e-03 | 9 | 202 | 2 | EFO_0004739 | |
| Disease | gastritis | 1.63e-03 | 9 | 202 | 2 | EFO_0000217 | |
| Disease | Motor retardation | 1.63e-03 | 9 | 202 | 2 | C0424230 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 1.63e-03 | 9 | 202 | 2 | EFO_0004570, GO_0009410 | |
| Disease | metabolite measurement | IVD ALDH1A2 SYNE2 ANK3 UGT1A6 ICE1 REV3L CPS1 WDFY4 UGT1A1 MICAL2 | 1.75e-03 | 560 | 202 | 11 | EFO_0004725 |
| Disease | Nephroblastoma | 1.91e-03 | 36 | 202 | 3 | C0027708 | |
| Disease | bilirubin measurement, response to tenofovir | 2.02e-03 | 10 | 202 | 2 | EFO_0004570, EFO_0009279 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 2.02e-03 | 10 | 202 | 2 | EFO_0802185 | |
| Disease | vitamin D measurement | 2.31e-03 | 336 | 202 | 8 | EFO_0004631 | |
| Disease | diastolic blood pressure, systolic blood pressure | BNC2 TRAF3 RTF1 SPON1 SVIL OSBPL6 SMG9 NPAS2 ANK3 C16orf96 C2CD3 SETBP1 | 2.36e-03 | 670 | 202 | 12 | EFO_0006335, EFO_0006336 |
| Disease | Lewy body dementia | 2.41e-03 | 39 | 202 | 3 | EFO_0006792 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 2.46e-03 | 11 | 202 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | plasma N-desmethylclozapine measurement | 2.46e-03 | 11 | 202 | 2 | EFO_0600039 | |
| Disease | histidine betaine (hercynine) measurement | 2.46e-03 | 11 | 202 | 2 | EFO_0800972 | |
| Disease | X-21796 measurement | 2.46e-03 | 11 | 202 | 2 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 2.46e-03 | 11 | 202 | 2 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 2.46e-03 | 11 | 202 | 2 | EFO_0010219 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 2.63e-03 | 200 | 202 | 6 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 2.94e-03 | 12 | 202 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | chronic kidney disease (implicated_via_orthology) | 2.94e-03 | 12 | 202 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | biliverdin measurement | 2.94e-03 | 12 | 202 | 2 | EFO_0021033 | |
| Disease | unipolar depression, multiple sclerosis | 2.94e-03 | 12 | 202 | 2 | EFO_0003761, MONDO_0005301 | |
| Disease | level of Phosphatidylcholine (14:0_18:1) in blood serum | 2.94e-03 | 12 | 202 | 2 | OBA_2045062 | |
| Disease | myocardial infarction | 2.96e-03 | 350 | 202 | 8 | EFO_0000612 | |
| Disease | cholelithiasis | 3.18e-03 | 88 | 202 | 4 | EFO_0004799 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 3.19e-03 | 43 | 202 | 3 | DOID:9261 (is_marker_for) | |
| Disease | triglycerides in large LDL measurement | 3.19e-03 | 43 | 202 | 3 | EFO_0022319 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 3.19e-03 | 144 | 202 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Schizophrenia | CYP1A2 ARHGAP32 CHGA CMYA5 ALDH1A2 KCNJ3 HRH1 DGCR8 QKI NPAS2 VSNL1 ANK3 EGR3 ATP2A2 | 3.20e-03 | 883 | 202 | 14 | C0036341 |
| Disease | childhood trauma measurement, smoking behaviour measurement | 3.63e-03 | 45 | 202 | 3 | EFO_0005671, EFO_0007979 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 3.63e-03 | 45 | 202 | 3 | DOID:3748 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKTGAMKNLLAPMDT | 266 | Q14146 | |
| SLRMSPVKGMQEKGE | 101 | Q15699 | |
| KLVMMFEGKANESSP | 121 | Q9BQI0 | |
| KAMDEDNKAASQTMP | 11 | Q86UN6 | |
| MALSMPLNGLKEEDK | 1 | Q9Y696 | |
| KAKTEEMPQLNFGMA | 186 | Q8WY36 | |
| GMENMSEVKEKPCVS | 1266 | Q68DQ2 | |
| EMSPGMSVKDFSKHN | 681 | Q6ZN30 | |
| MTSSKIEMPGEVKAD | 1 | O94788 | |
| SMEMPAEVGQKSQKR | 131 | P33076 | |
| AKTVGLPTAMAAKML | 871 | Q9UDR5 | |
| GSIAATLKMKQGPMT | 1371 | Q12802 | |
| KRPQSDRSAQKGMMT | 851 | Q96L96 | |
| SKNKQMLPGGSKEMS | 41 | A7E2U8 | |
| ELLGINKATPKMSMG | 216 | Q8WXA8 | |
| GLPKTMSQKEMEQLF | 131 | Q14576 | |
| KMDTGVKTSQEPEMA | 191 | Q8IYA2 | |
| DGETSVQPMMTKIKT | 276 | Q8WYQ5 | |
| SLMNSSEAAMKKTLP | 71 | A6NGY3 | |
| KAPMDISSMEKKLNG | 476 | Q9BXF3 | |
| MGMTDDVSTIKAPRK | 1031 | Q14004 | |
| MKSDVKMSLSLPDKN | 746 | Q03468 | |
| VNTMPKEGAGVDMKA | 496 | Q5H9R4 | |
| GEVFKMMQAEETPKT | 271 | O75185 | |
| ANKMLQTKDGKMPSE | 206 | Q8WWH4 | |
| AIKGMQEASMKLTES | 66 | P49418 | |
| MPKNVVFVIDKSGSM | 271 | Q14624 | |
| INDMKKSPEIISGRM | 41 | Q9Y5U8 | |
| LKGELSARMKIPSNM | 721 | Q15042 | |
| EECMSKKESFAPGTM | 41 | Q96IZ5 | |
| GMKMESVQSERKPFD | 181 | P49116 | |
| RDQDMSSPTTMKKPE | 306 | O00712 | |
| PAAEGEDSLKKMQLM | 181 | Q96PU8 | |
| MAKESMDSVKTPDQA | 486 | Q6ZRP7 | |
| SMIPHLESGMKSSKS | 56 | Q08116 | |
| DGTAINKPLSEKMML | 436 | P05177 | |
| MAQEKMKLGFKSLPS | 1 | Q6P4D5 | |
| SDPKPAFSKMNGSMD | 181 | Q8IWT6 | |
| ELSSMLPGNTRKMDK | 31 | Q99743 | |
| KAIPIMKTRSGMQFS | 1486 | Q96PE2 | |
| EMMGLGDVKLTPATK | 966 | O14497 | |
| SLEGMQKMEKEESPT | 511 | Q9UJX3 | |
| MAKLSKLASNGTPMG | 51 | O14526 | |
| MVKATDKGSPPMSEI | 1636 | Q14517 | |
| AEATPMLKTLSNATM | 191 | Q9H0Q0 | |
| MASTPMGNEGEKKSS | 1 | P0DO92 | |
| LIDQMNASGPIKEKM | 806 | Q9NRZ9 | |
| MTGKEMASVGEPDKL | 596 | Q7RTP6 | |
| MGDKKSMFNEELDLP | 2766 | Q8NEZ4 | |
| DMLMQERITPFTKGK | 391 | Q3ZCV2 | |
| APSKETEMALAKDMA | 251 | P27816 | |
| MKMAAPTANKAASLG | 1 | Q8IYB1 | |
| GTMSPKAFLEEAQVM | 296 | P09769 | |
| KGLANTMKSPLSMLE | 446 | Q6ZRQ5 | |
| GKTPDAMKAAMALEK | 91 | P02792 | |
| LPFQGKDRKETMTMI | 266 | P51812 | |
| EATEGLMNLSPSAMK | 941 | P46020 | |
| MSPQVLKKSMSAGSE | 1131 | Q2KJY2 | |
| PCMKGGTDMQTKKEA | 381 | Q9ULE4 | |
| MEKGKLLSSQEGMIS | 281 | Q15751 | |
| PPTAAAGSMMKKDAL | 36 | P17535 | |
| PDSLSSSKDMVKMFP | 1081 | Q5H9U9 | |
| KVMPKMDQDSLSSSL | 26 | P37268 | |
| SEMFMEGANKIIPKL | 2131 | Q5CZC0 | |
| KSQMKEDPDMASAVA | 11 | Q14232 | |
| MNVTPEVKSRGMKFA | 1 | Q5T3I0 | |
| PLLKSAETEKEMATM | 841 | P13535 | |
| EKMTMNKELSPDAAA | 6 | O95544 | |
| MGENMTDDPRSFKKI | 3426 | Q9Y6V0 | |
| MPTSKSDLEAKEGQM | 556 | A6NKB5 | |
| NTKNSALMAKKAPTM | 171 | O43660 | |
| DDMQSLASLMSVKPS | 166 | Q8N3D4 | |
| KSPLSETMDVKPSDM | 546 | Q9NPC7 | |
| FKSLNPTGTMKMSVD | 431 | Q0VAA2 | |
| PMMSEKTRQNKLAEA | 11 | Q8N9W4 | |
| AMSEPNAGSDVVSMK | 166 | P26440 | |
| GFEMKAQPSNRMKTE | 261 | P78316 | |
| ESEPSEMKAMALKGG | 681 | A7KAX9 | |
| KDGVMGMNSIEPAKE | 501 | Q8TDB8 | |
| ESSPAANVSVMDGKM | 206 | Q9BZF3 | |
| SMKDHVTKPTAMGQG | 66 | Q86XD5 | |
| EVKDPNMKGAMLTNT | 201 | Q7Z6E9 | |
| AMPKFSASSMTKLPQ | 1341 | A2PYH4 | |
| MMTKNLAGKTPTDLV | 306 | Q9GZV1 | |
| NKPSRTSMSKMFVKG | 501 | P16615 | |
| MLRKGPAEDMSSKLN | 1451 | Q14008 | |
| NMEKTLKGLNSESMT | 886 | P31327 | |
| PSEAKESMDKNKMGL | 81 | P50213 | |
| SEGKTVLSKMMGSPK | 546 | Q9Y2F5 | |
| VLSKMMGSPKSEFTK | 551 | Q9Y2F5 | |
| GPDTSLKTMELMKEG | 211 | Q9H2M3 | |
| SAMATPENLASLMKG | 226 | Q14781 | |
| KLRNAMVISAMKSSP | 326 | Q4AC94 | |
| PTMAQMEKALSIGFE | 61 | P16070 | |
| AMVATKQAMSPEDKK | 666 | A6NNT2 | |
| MLQDAISKMDPTDAK | 316 | Q16543 | |
| ETGTLSMDVKVPMDK | 611 | Q7Z3S7 | |
| NSVSSPMAEKLKEMG | 171 | Q9BPX7 | |
| MQPLTKDAGMSLSSV | 1 | Q68DX3 | |
| MTGKLAEKLPVTMSS | 1 | Q06889 | |
| MGDVKESKMQITPET | 1 | Q6PGQ7 | |
| ASNADKMVSNKEMPK | 2901 | Q8N3K9 | |
| SGEKMPVKMIGDILS | 1306 | Q15811 | |
| CMAMDQGKIPSEIKA | 76 | O60519 | |
| MKDSENKGASSPDME | 1 | O75061 | |
| MGLFKKTEMVSSVPA | 201 | A2RUB6 | |
| ISASTMTMKKEGPGE | 3726 | Q12955 | |
| MDKMKSPRVALSAAT | 901 | O43303 | |
| TLSMPKDEAANGLMA | 176 | Q9BWP8 | |
| DSKGNKIIMTPDMCI | 641 | Q8IY82 | |
| PSASSASLEKRMKMV | 326 | Q9Y5N1 | |
| KGSPKESMEASPEAM | 431 | Q8IWC1 | |
| GKDGVMEMNSIEPAK | 476 | P11169 | |
| EQSMDMGTSALSKKP | 71 | Q4VXA5 | |
| MASVGNMDEKSNKLL | 141 | Q96MM7 | |
| SPKSMAVEESISMKP | 966 | Q9ULL0 | |
| AAMAMPADTNKAFKT | 206 | Q9P0I2 | |
| EDKMCEGNKTTMASP | 11 | P35367 | |
| KPMQKLVSSPEMESN | 696 | Q8NDH2 | |
| VEEPLNAFKESKGMM | 306 | Q08722 | |
| MSSGKVDPVSLGKMD | 411 | Q7Z2K8 | |
| GSLPDMNKMLDKEDF | 411 | P13807 | |
| DSLVLQMKSMSVGDP | 526 | Q14147 | |
| TKKDTAQIMFMAGLP | 181 | Q9Y267 | |
| KKPDREEIQMSNMGS | 881 | O60716 | |
| MENDPVMGTHKSTKQ | 466 | Q8NC60 | |
| SMDMSPIKIVKNPDG | 456 | Q14562 | |
| SESPGMLTKLQIKQM | 131 | O43395 | |
| GKEMASAQEPDKLSM | 596 | O94851 | |
| ADTMPFVMLTRKGNK | 1166 | Q9HAU5 | |
| MKTEMKQGAPTSFLP | 141 | Q9BUJ2 | |
| MVSSQKLEKPIEMGS | 1 | Q9BUB5 | |
| GAPESVQKAKMMLDD | 196 | Q92945 | |
| KAEGLPKMNSSIMAN | 251 | Q2WGJ9 | |
| KEAMFSAGMQLPTLD | 456 | Q92541 | |
| RAKVSGKMLSQPMST | 711 | Q8NET4 | |
| EAVLDAMAKSPLKMS | 911 | Q5VT97 | |
| AMAKSPLKMSSNGCE | 916 | Q5VT97 | |
| MESGKTASPKSMPKD | 1 | Q16594 | |
| KMNPADGSMCKAETS | 586 | Q9HCB6 | |
| MSLLNKPKSEMTPEE | 1 | P62316 | |
| LGDEPKEFSMAKMNA | 1011 | O95425 | |
| GTEEAPKVFKMAASM | 21 | Q8IUX1 | |
| LKGQMLKFSSMAPDL | 7396 | Q8NF91 | |
| KESLMVLNSSEGKMP | 2061 | Q8WXH0 | |
| EMKKGKSNESEGSMN | 1496 | B5MCY1 | |
| LPEMVAAMKGNSTLK | 691 | Q15345 | |
| MNGLVTSSPEMFKLK | 311 | A6NI28 | |
| GFEMLQNPVKDSKEM | 1711 | Q9HCM1 | |
| SMDAMGLSNKKPNTV | 441 | P47736 | |
| GKSMVMSLLSANTPE | 216 | Q9H0W8 | |
| NMLMERSKEKGLPSV | 476 | Q9P0U3 | |
| TKSGEKQPDASMMQI | 166 | Q8TF72 | |
| DAIRTSLGPKGMDKM | 46 | P50991 | |
| QMEKMLFPLKSPSAT | 41 | Q6ZUB1 | |
| NSMPMEERKAKAAAI | 531 | Q9NVU7 | |
| ITLKNAMKMESGDSG | 416 | Q9HAS3 | |
| DMEGGISSPVKKTEM | 316 | P08651 | |
| LIQKSKSMPNLGDDM | 516 | O94875 | |
| EKNSSVKVPMMFRSG | 231 | Q8IW75 | |
| LSDEESSMPLAGMKK | 721 | Q13023 | |
| VNSPMNKGDTEVMKC | 21 | P10645 | |
| VGLDQMAKMTESSLP | 626 | P35749 | |
| APMTKIKKLMGSTEQ | 111 | Q8N782 | |
| FGMKAPEMTNELKND | 646 | Q5QJE6 | |
| PKGVNMEELMSKLSA | 311 | Q6XR72 | |
| MGMEDVPLATSKKLS | 221 | Q86XZ4 | |
| MGKPSSMDTKFKDDL | 1 | Q9UM82 | |
| MESSKKMDSPGALQT | 1 | Q13114 | |
| MMTTLQNKEECGKGP | 1 | Q9H0M4 | |
| TLMKMGLKDTPTQED | 91 | Q9NQW7 | |
| EASMPKIKELMGSTD | 126 | Q96N58 | |
| MGKQNSKLAPEVMED | 1 | P62760 | |
| NRGDKMEMLPDTTGK | 476 | Q9UMS6 | |
| QMEMEIAKSEKFGSP | 1181 | Q96T58 | |
| KPHPSNMMSKLSSED | 131 | Q8NEJ9 | |
| LFKQKDMPLMGSAVD | 1261 | O60673 | |
| QKLTMGMLKSPNTAI | 216 | Q9C0H9 | |
| MEMPTATQKTDTGLT | 61 | Q96C74 | |
| KGVFKSTTMEGAMLP | 511 | Q9Y5W7 | |
| ASKGEMSPMVVETLK | 3636 | Q15413 | |
| LRKMSPTGNEMKSTT | 6 | O95171 | |
| TSAKNIRMMGKPLTS | 1241 | Q6ZT07 | |
| PELKDKPIAVGSMSM | 121 | Q9UBT6 | |
| SLGSMVSEIPEKKAM | 306 | P22309 | |
| LSSAMKLMPGRQAKD | 2201 | Q6ZS81 | |
| SMTNLVKMGFPSKTD | 401 | Q9HAV4 | |
| KNMLSDKDPMLGSAS | 46 | Q92576 | |
| GKAVEATLMSPKGMA | 1276 | Q9P273 | |
| ATLMSPKGMAVDKNG | 1281 | Q9P273 | |
| SNSHSMKKDPVMPQK | 416 | A0A0J9YWL9 | |
| MVPLGDSNSHSMKKD | 826 | A0A0J9YWL9 | |
| ISKMIEDSGPGMKVL | 11 | Q9NRW7 | |
| MKTQSFVAKMLGVPA | 771 | P47989 | |
| DPEKGMGKDTSSLHM | 641 | Q6ZSY5 | |
| SSAMIKDLSQEFGMP | 386 | Q6ZUG5 | |
| LPNMMKLSLGSSGKS | 556 | Q63HK5 | |
| DSTPKMKMEIGDTLS | 111 | Q9BYW2 | |
| SKMMSPLKNSSDGLT | 541 | Q8TCN5 | |
| SMEQAVLDSMGSGKK | 586 | Q9Y6X8 | |
| PDSGLMGNSMLVKKE | 271 | Q9ULD9 | |
| KSVMDSMKQTGVDPT | 1216 | Q9ULD9 | |
| PKKMVIMESGESAAS | 126 | Q86YA3 | |
| AGENMMKGSELTPKQ | 271 | Q9P0L1 | |
| KCKAGMSNPALTMEN | 351 | Q9UIJ5 | |
| RLMKSESMPVQLNKG | 516 | Q92609 | |
| KQSGSSSELLVEMMP | 336 | Q9C0G0 | |
| MKVDALMSSVPKRAS | 926 | Q9NYU1 | |
| LGSMVSEIPEKKAMA | 306 | P19224 | |
| AEMNEKLSKMGESSL | 686 | O60264 | |
| SGRMKKSDNKMGITP | 761 | Q12789 | |
| KELPPNGDTKSMVMD | 746 | Q8NFY4 | |
| NEGSVPTMMTRKKPA | 1351 | Q9Y6X0 | |
| PKTDGKKMADTSSMD | 1576 | Q8NFA0 | |
| SFEGMKMRSTKQEPN | 491 | Q8NBN3 | |
| MKADMGGTNILSPLK | 431 | Q5TIE3 | |
| TKMLSDPMSQSVADL | 456 | P48549 | |
| ATGILKSFMTKNPTM | 581 | P24723 | |
| KSFMTKNPTMRLGSL | 586 | P24723 | |
| PSDMPQIKAKVAAMG | 806 | B0I1T2 | |
| KLMAMEQGKTLPSAT | 226 | Q7Z6G3 |